Zydus Bags Tentative USFDA Nod for $2.67 Billion Rifaximin — Blockbuster or Waiting Room?

🧪 About the Drug

• Generic Name: Rifaximin Tablets, 550 mg
• Reference Brand: Xifaxan
• Use: Treatment of IBS-D in adults
• US Market Size: $2,672.9 million (as per IQVIA MAT March 2025)

EduDecode: IBS-D is that thing where your stomach disagrees with every buffet you ever loved. And Rifaximin is the peace treaty.

🏭 Where It’ll Be Made

• Zydus’ manufacturing site at SEZ II, Ahmedabad
• This plant is already part of Zydus’ US exports ecosystem

📦 Zydus’ USFDA Track Record